|
Diabetes medication changes |
||
| Participant |
Week 0 Total daily dose |
Week 16 Total daily dose |
|
|
||
| Participants with diabetes medications discontinued (n = 7 of 21) |
||
| 5 |
glipizide 10 mg metformin 1000 mg |
none |
| 6 |
glipizide 20 mg metformin 1500 mg |
none |
| 7 |
metformin 2000 mg rosiglitazone 8 mg |
none |
| 9 |
metformin 1000 mg |
none |
| 15 |
metformin 1000 mg |
none |
| 22 |
metformin 1000 mg |
none |
| 24 |
metformin 1000 mg |
none |
| Participants with diabetes medications reduced (n = 10 of 21) |
||
| 3 |
70/30 insulin 50 units metformin 1000 mg |
metformin 1000 mg |
| 11 |
metformin 2000 mg glyburide 20 mg |
metformin 2000 mg |
| 16 |
metformin 2000 mg pioglitazone 45 mg glipizide 20 mg |
metformin 2000 mg |
| 21 |
metformin 1500 mg pioglitazone 30 mg |
metformin 1000 mg |
| 8 |
NPH 145 units metformin 1000 mg |
NPH 25 units metformin 1000 mg |
| 13 |
70/30 insulin 70 units metformin 2550 mg |
70/30 insulin 35 units metformin 2550 mg |
| 23 |
70/30 insulin 110 units pioglitazone 45 mg |
70/30 insulin 80 units pioglitazone 45 mg metformin 1000 mg |
| 25 |
NPH 70 units, R 30 units metformin 2000 mg pioglitazone 45 mg |
NPH 8 units metformin 2000 mg pioglitazone 45 mg |
| 27 |
70/30 insulin 86 units metformin 2000 mg |
70/30 insulin 18 units metformin 2000 mg |
| 28 |
NPH insulin 110 units lispro insulin 90 units glipizide 20 mg |
NPH insulin 30 units glipizide 20 mg |
| Participants with diabetes medications unchanged (n = 4 of 21) |
||
| 1 |
none |
none |
| 2 |
metformin 1700 mg |
metformin 1700 mg |
| 10 |
none |
none |
| 26 |
metformin 2000 mg |
metformin 2000 mg |
Yancy et al. Nutrition & Metabolism 2005 2:34 doi:10.1186/1743-7075-2-34 |
||